Search Within

Otavia Caballero

Formats
  1. Journal Article (27)
  2. Book Section (2)
  3. Meeting Abstract (1)
Groups
  1. Department of Pathology and Laboratory Medicine (8)
  2. Sloan Kettering Institute Postdocs (2)
  3. Department of Medicine (1)
  4. GSK Faculty (1)
  5. Melanoma and Immunotherapeutics Service (1)
  6. Solid Tumor Oncology Division (1)
People
  1. Andrew Simpson (12)
  2. Lloyd Old (12)
  3. Achim Jungbluth (8)
  4. Ramon Chua (6)
  5. Tzeela Cohen (4)
  6. Sacha Gnjatic (3)

More People

Years
  1. 2021 (1)
  2. 2017 (1)
  3. 2016 (1)
  4. 2015 (1)
  5. 2014 (1)
  6. 2013 (1)

More Years

Publications
  1. Cancer Immunity (6)
  2. Leukemia Research (2)
  3. Oncoscience (2)
  4. Oncotarget (2)
  5. Proceedings of the National Academy of Sciences of the United States of America (2)
  6. ACS Chemical Biology (1)

More Publications

Publishers
  1. Academy of Cancer Immunology (6)
  2. Impact Journals (4)
  3. Springer (3)
  4. American Association for Cancer Research (2)
  5. Elsevier Ltd (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The cancer testis antigens CABYR-a/b and CABYR-c are expressed in a subset of colorectal cancers and hold promise as targets for specific immunotherapy
    Journal Article

    Kumara, H. M. C. S.; Sutton, E.; Caballero, O. L.; Su, T.; Yan, X.; Ahmed, A.; Herath, S. A. C.; Cekic, V.; Njoh, L.; Kirchoff, D. D.; more...
    Oncotarget (2021)

    Fulltext@MSK | Save
  • P-cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring
    Journal Article

    Shantha Kumara, H. M. C.; Bellini, G. A.; Caballero, O. L.; Herath, S. A. C.; Su, T.; Ahmed, A.; Njoh, L.; Cekic, V.; Whelan, R. L.
    Oncoscience (2017)

    Fulltext@MSK | Save
  • Mycoplasma infection alters cancer stem cell properties in vitro
    Journal Article

    Gedye, C.; Cardwell, T.; Dimopoulos, N.; Tan, B. S.; Jackson, H.; Svobodová, S.; Anaka, M.; Behren, A.; Maher, C.; Hofmann, O.; more...
    Stem Cell Reviews and Reports (2016)

    Fulltext@MSK | Save
  • Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target
    Journal Article

    Shantha Kumara, H. M. C.; Kirchoff, D.; Caballero, O. L.; Su, T.; Ahmed, A.; Herath, S. A. C.; Njoh, L.; Cekic, V.; Simpson, A. J.; Cordon-Cardo, C.; more...
    Oncoscience (2015)

    Fulltext@MSK | Save
  • CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage
    Journal Article

    Urias, Ú; Marie, S. K. N.; Uno, M.; Da Silva, R.; Evagelinellis, M. M.; Caballero, O. L.; Stevenson, B. J.; Silva, W. A. Jr; Simpson, A. J.; Oba-Shinjo, S. M.
    Journal of Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Effects of CT-Xp gene knock down in melanoma cell lines
    Journal Article

    Caballero, O. L.; Cohen, T.; Gurung, S.; Chua, R.; Lee, P.; Chen, Y. T.; Jat, P.; Simpson, A. J. G.
    Oncotarget (2013)

    Fulltext@MSK | Save
  • Cancer/testis antigens: Potential targets for immunotherapy
    Book Section

    Caballero, O. L.; Chen, Y. T.
    In Wang, R. (Eds.) Innate Immune Regulation and Cancer Immunotherapy (2012)

    Fulltext@MSK | Save
  • Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells
    Journal Article

    Tsuji, T.; Matsuzaki, J.; Caballero, O. L.; Jungbluth, A. A.; Ritter, G.; Odunsi, K.; Old, L. J.; Gnjatic, S.
    Journal of Immunology (2012)

    Fulltext@MSK | Save
  • Humanized Lewis-Y specific antibody based delivery of STAT3 siRNA
    Journal Article

    Ma, Y.; Kowolik, C. M.; Swiderski, P. M.; Kortylewski, M.; Yu, H.; Horne, D. A.; Jove, R.; Caballero, O. L.; Simpson, A. J. G.; Lee, F. T.; more...
    ACS Chemical Biology (2011)

    Fulltext@MSK | Save
  • Cancer/testis (CT) antigens are preferentially expressed in hormone receptor negative breast cancers and may offer therapeutic targets
    Meeting Abstract

    Ross, D. S.; Caballero, O.; Lee, P.; Riedel, E.; Hoda, S.; Old, L.; Neville, A.; Chen, Y.
    Laboratory Investigation (2010)

    Fulltext@MSK | Save